Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms
about
Epigenetics: connecting environment and genotype to phenotype and diseaseHematologic manifestations of Helicobacter pylori infectionEndoscopic surveillance strategy after endoscopic resection for early gastric cancer.NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associationsVEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer.Immunoexpression of cyclooxygenase-2 in primary gastric carcinomas and lymph node metastasesReview article: Helicobacter pylori eradication for the prevention of gastric cancer.Short-term celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model.Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions.New insights into the inactivation of gastric tumor suppressor RUNX3: the role of H. pylori infection.Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4 +3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese.Association between TNF-α rs1799964 and RAF1 rs1051208 MicroRNA binding site SNP and gastric cancer susceptibility in an Iranian population.Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression.DNA repair enzyme polymorphisms and oxidative stress in a Turkish population with gastric carcinoma.No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in JapaneseSignificant association of RUNX3 T/A polymorphism at intron 3 (rs760805) with the risk of gastric atrophy in Helicobacter pylori seropositive Japanese
P2860
Q28730790-A0974442-3B15-4237-A705-FBD4B27347F3Q33417972-6D4E1166-E4D3-4BFD-9287-1F42EA022239Q33628113-E2D0F708-CC7E-42DA-BAC7-50876F4E02DAQ34100038-C6D3DCF5-E018-4E2A-977E-8F4EA746C43CQ34373527-A4851BBD-59E1-418D-B723-B070F9A0E271Q35776109-8AEC7328-1463-40AD-BA2B-5E83FD7192E9Q37032707-642DE1B5-D9F5-4CCC-856D-1FE9BCBE2DCDQ37394555-20CEFAA0-0CFC-421D-821F-F21CB3894C13Q37821283-4CC72B40-FEED-4C13-B965-CB4E73E78C7DQ37832453-4A15E42F-EE57-41F6-B9B3-480BF8A6ADC0Q44376408-F6D10AC9-414C-49CA-98AB-57ED8A1C535FQ45908741-B74E0C2F-9F51-4AFB-A5A1-05E5486DFC69Q46376244-89932675-F87A-4890-94BF-067F4FBB28C2Q51886947-B88C35A7-2C81-4704-A761-532C3355BB0AQ57918430-DBEDF44D-988C-4E94-BFA5-35282D5264F7Q57918519-088AF30E-CDAD-4877-8E8A-D8EC1C053BF6
P2860
Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Helicobacter pylori eradicatio ...... ecular and cellular mechanisms
@ast
Helicobacter pylori eradicatio ...... ecular and cellular mechanisms
@en
type
label
Helicobacter pylori eradicatio ...... ecular and cellular mechanisms
@ast
Helicobacter pylori eradicatio ...... ecular and cellular mechanisms
@en
prefLabel
Helicobacter pylori eradicatio ...... ecular and cellular mechanisms
@ast
Helicobacter pylori eradicatio ...... ecular and cellular mechanisms
@en
P2093
P2860
P356
P1476
Helicobacter pylori eradicatio ...... ecular and cellular mechanisms
@en
P2093
Hiroaki Murata
Masahiko Tsujii
Masakazu Yasumaru
Masato Komori
Norio Hayashi
Shingo Tsuji
Shuji Ishii
Sunao Kawano
Yoshiaki Sasayama
P2860
P304
P356
10.3748/WJG.V12.I11.1671
P407
P577
2006-03-01T00:00:00Z